Matching-adjusted indirect comparison and cost-effectiveness of mitoxantrone hydrochloride liposome versus Chidamide in relapsed or refractory peripheral T-cell lymphoma in China
PLM60 was estimated to be a cost-effective treatment for R/R PTCL compared with CS055 from a Chinese healthcare perspective, which provided patients with an effective and cost-saving treatment option.
Authors
- Xiaoning He (ORCID: https://orcid.org/0000-0001-9080-7219)
- Ying Liu (ORCID: https://orcid.org/0000-0002-1647-2323)
Institutions
- Tianjin University (CN)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1080/14737167.2025.2482667
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47